top of page

The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

FoodBev Media Logo
Access more as a FoodBev subscriber

Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...

Domino September - Website Banner - GS1 - 300x250.gif
DSM-Firmenich sells 6.7m ordinary shares through accelerated bookbuild
FoodBev Media

FoodBev Media

25 May 2023

DSM-Firmenich sells 6.7m ordinary shares through accelerated bookbuild

DSM-Firmenich has launched the sale of up to 6.7 million existing ordinary shares through an accelerated bookbuild offering of shares (Share Placement). The news follows the completion of the merger between DSM and Firmenich at the start of the month. The company has also raised total proceeds of €733 million following the sale of its ordinary shares to institutional investors, representing approximately 2.5% of DSM-Firmenich's share capital, at a price of €109.50 per share. The book was multiple times oversubscribed, indicating that investors were eager to buy the company’s shares. According to a statement, DSM-Firmenich intends to use the net proceeds of the Share Placement to "fund the cash consideration payable by the company in relation to the buy-out procedure in accordance with Dutch law that the company commenced in order to acquire the DSM ordinary shares that have not been tendered in the voluntary public exchange offer launched by the company for all the issued and outstanding DSM ordinary shares”. Closing and settlement of the Share Placement is expected to occur on 29 May 2023.

Related posts
DSM-Firmenich offloads yeast business to Lesaffre
Mergers & Acquisitions

DSM-Firmenich offloads yeast business to Lesaffre

Meiji and DSM-Firmenich partner to reduce methane emissions
Sustainability

Meiji and DSM-Firmenich partner to reduce methane emissions

DSM-Firmenich and Deloitte partner on animal protein sustainability
Sustainability

DSM-Firmenich and Deloitte partner on animal protein sustainability

DSM-Firmenich completes sale of Jiangshan vitamin C plant in China
Business

DSM-Firmenich completes sale of Jiangshan vitamin C plant in China

DSM-Firmenich to separate Animal Nutrition & Health business
Nutrition

DSM-Firmenich to separate Animal Nutrition & Health business

DSM-Firmenich receives approval for HMOs in infant formula in Australia and New Zealand
Dairy

DSM-Firmenich receives approval for HMOs in infant formula in Australia and New Zealand

bottom of page